However, recent cancer dependency map studies utilizing CRISPR/Cas9 and small hairpin RNA–based genetic screens may represent valuable resources to identify novel therapeutic opportunities to target MYC-dependent cancer cells (Tsherniak et al., 2017; Meyers et al., 2017). The gene discussed is MYC; the disease is cancer.